APNIMED

Apnimed is a clinical-stage pharmaceutical company in Cambridge, MA, focused on developing oral medications for obstructive sleep apnea (OSA) and other sleep-related breathing diseases, with a goal of expanding treatment options beyond current devices and surgeries.